Bayer Healthcare has submitted its new eye drug to European regulators for approval to treat age-related macular degeneration (wet AMD). …

While many of its larger peers in the pharma sector are rushing to diversify into consumer health and generics, Bayer, …

Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

